Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhaled Medications

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...

Inhalational Anesthetics: Overview

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparison of high- and low-molecular-weight sensitizing agents causing occupational asthma: an evidence-based insight.

Expert review of clinical immunology·2024

Same author

Pancreatic Cancer Progression in a Patient With Lynch Syndrome Receiving Immunotherapy: A Cautionary Tale.

Journal of the National Comprehensive Cancer Network : JNCCN·2021

Same author

The classification of azodicarbonamide (ADCA) as a respiratory sensitiser; adding to the weight of evidence.

Regulatory toxicology and pharmacology : RTP·2018

Same author

An Official American Thoracic Society Workshop Report: Presentations and Discussion of the Sixth Jack Pepys Workshop on Asthma in the Workplace.

Annals of the American Thoracic Society·2017

Same author

An official American Thoracic Society Workshop Report: presentations and discussion of the fifth Jack Pepys Workshop on Asthma in the Workplace. Comparisons between asthma in the workplace and non-work-related asthma.

Annals of the American Thoracic Society·2015

Same author

Manuscript cited in "Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement".

The European respiratory journal·2014

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

New methodology for specific inhalation challenges with occupational agents.

Simon Caron¹, Jean-Christian Boileau, Jean-Luc Malo

¹Department of Chest Medicine, Sacré-Coeur Hospital, Montreal, Canada.

Respiratory Research

|June 11, 2010

Summary

This summary is machine-generated.

A new device, GenaSIC, enables safe and controlled inhalation challenges for diagnosing occupational asthma (OA). It accurately generates various agents, proving feasible for patient testing and identifying asthmatic reactions to common workplace exposures.

More Related Videos

Development of a Nose-only Inhalation Toxicity Test Chamber That Provides Four Exposure Concentrations of Nano-sized Particles

Development of a Nose-only Inhalation Toxicity Test Chamber That Provides Four Exposure Concentrations of Nano-sized Particles

Published on: March 18, 2019

Methodology for Sputum Induction and Laboratory Processing

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Related Experiment Videos

Last Updated: Jun 12, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Development of a Nose-only Inhalation Toxicity Test Chamber That Provides Four Exposure Concentrations of Nano-sized Particles

Development of a Nose-only Inhalation Toxicity Test Chamber That Provides Four Exposure Concentrations of Nano-sized Particles

Published on: March 18, 2019

Methodology for Sputum Induction and Laboratory Processing

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Area of Science:

Occupational Medicine
Allergy and Immunology
Biomedical Engineering

Background:

Inhalation challenges are crucial for diagnosing occupational asthma (OA).
Traditional methods lacked exposure monitoring and control.
A need existed for a standardized and reliable exposure system.

Purpose of the Study:

To design and assess the feasibility of the GenaSIC equipment for generating various inhalation agents.
To evaluate the GenaSIC's utility in patients suspected of having OA.

Main Methods:

The GenaSIC device was developed to generate diverse agents (lactose, flour, malt, isocyanates, formaldehyde, N-butyl acetate).
Real-time measurements ensured precise and stable agent concentrations.
Forty-four subjects underwent controlled exposures to control and/or suspected occupational agents.

Main Results:

GenaSIC generated agents with stable concentrations, unaffected by normal breathing.
Five out of seven subjects exposed to dry particles (flour, malt) showed immediate asthmatic reactions.
Four out of ten subjects exposed to isocyanates had positive reactions, indicating OA.

Conclusions:

The GenaSIC equipment facilitates reliable and safe inhalation challenges.
It is effective for diagnosing occupational asthma using dry particles, formaldehyde, and isocyanates.